MEI Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.57
|
|
Average Rating
|
3.75
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.14
|
-0.12
|
0.02
|
14.29%
|
|
2022-06-30
|
-0.19
|
-0.12
|
0.07
|
36.84%
|
|
2022-03-31
|
-0.18
|
-0.07
|
0.11
|
61.11%
|
|
2021-12-31
|
-0.20
|
-0.05
|
0.15
|
75.00%
|
|
2021-09-30
|
-0.13
|
-0.11
|
0.02
|
15.38%
|
|
2021-06-30
|
-0.17
|
-0.05
|
0.12
|
70.59%
|
|
2021-03-31
|
-0.16
|
-0.28
|
-0.12
|
-75.00%
|
|
2020-12-31
|
-0.13
|
-0.10
|
0.03
|
23.08%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.12
|
|
2022-06-30
|
-0.35
|
|
2021-06-30
|
-0.45
|
|
2020-06-30
|
-0.53
|
|
2019-06-30
|
-0.75
|
|
2018-06-30
|
-0.92
|
|
2017-06-30
|
0.06
|
|
2016-06-30
|
-0.61
|
|
2015-06-30
|
-1.21
|
|
2014-06-30
|
-1.35
|
|
2013-06-30
|
-1.59
|
|
2012-06-30
|
-3.41
|
|
2011-06-30
|
-5.32
|
|
2010-06-30
|
-6.45
|
|
2009-06-30
|
-9.19
|
|
2008-06-30
|
-10.80
|
|
2007-06-30
|
-13.20
|
|
2006-06-30
|
-7.80
|
|
2005-06-30
|
-6.60
|
|
2004-06-30
|
-8.27
|